Zdrowie i gospodarka · 04/03/2026
FDA Releases Final Guidance on Postapproval Safety Data Management
The FDA has released a final guidance on postapproval safety data management, clarifying the use of new data sources and terminology for adverse event reporting, replacing a draft guidance issued in 2024 and a 2003 final guidance.